<unk>  is used to reverse neuromuscular blockade after administration of the aminosteroid non-depolarizing neuromuscular-blocking agents such as vecuronium or rocuronium. In the European Union<unk>  is indicated for the reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.<unk>  is only recommended for routine reversal of rocuronium-induced blockade in children and adolescents.
Sugammadex
Eptazocine
Pentazocine
Iopentol
Fomepizole
Etomidate
Neostigmine
Bremazocine